This indicates that CAPE plays a role similar to the late autophagy inhibitor BAF 1, thereby inhibiting the combination of autophagosomes and lysosomes, inhibiting the autophagy flux of colon cancer cells, and improving chemotherapy sensitivity (Fig. 6). The gene discussed is SMC2; the disease is colonic neoplasm.